Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cell Therapy Catapult & the UK Stem Cell Foundation Agree to Collaborate

Published: Wednesday, April 10, 2013
Last Updated: Wednesday, April 10, 2013
Bookmark and Share
Working together on next-generation medicines for patient benefit.

The Cell Therapy Catapult (CT Catapult), which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, and the UK Stem Cell Foundation, a charity focused on the advancement of stem cell treatments towards the clinic, are pleased to announce that they will be working together to progress promising stem cell-based therapies in the UK. The two organisations, which have entered into a memorandum of understanding to cover their co-operation, are both focused on translational activities, moving potential therapeutic approaches on from early-stage research to the later stages of development.

The CT Catapult and the charity aim to build a pipeline of projects that meet their criteria for support and funding on the route to commercialisation. Since 2005 the UKSCF has supported projects in a range of indications from spinal cord repair, ophthalmic, liver and cardiac disease, and tendon repair. Building on the UK's early stage research base, the CT Catapult is working on building a similarly broad pipeline. The two organisations will meet regularly to discuss projects and potential support packages, including other partners, contributing to the growth of the UK's emerging cell therapy industry.

Keith Thompson, CEO of the Cell Therapy Catapult, said, 'With the philanthropic sector an increasingly important source of life sciences research funding globally, we are very pleased to be working with the UK Stem Cell Foundation on the development of much needed therapies. The charity is a major UK funder in this area, and exemplifies the kind of high quality organisation the Cell Therapy Catapult expects to collaborate with as it works to build a thriving UK cell therapy industry.'

UKSCF’s CEO Lil Shortland said, 'It is clear that some of the projects we support fit within the remit of the Catapult and would benefit from the specialist support that it can provide. It is vital that there is a joined up approach between public, private and third sector organisations supporting the development of regenerative medicine products in the UK. Each sector has a role to play in realising the potential of stem cells to deliver not just health benefits but economic benefits for the UK and beyond.'


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UCL, Imperial & Cell Therapy Catapult Collaborate
A novel cell therapy approach to the treatment of acute myeloid leukaemia is to be developed further via the innovative partnership.
Tuesday, May 20, 2014
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Atmosphere Acidity Minimised to Preindustrial Levels
Sheet ice study shows acidic pollution of the atmosphere has now almost returned to preindustrial levels.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!